Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury

Lai Ming Yung, Ying Wei, Tao Qin, Yumei Wang, Charles D. Smith, Christian Waeber

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background and Purpose-: Cerebral preconditioning provides insights into endogenous mechanisms that protect the brain from ischemic injury. Hypoxia and the anesthetic isoflurane are powerful preconditioning agents. Recent data show that sphingosine 1-phosphate receptor stimulation improves outcome in rodent models of stroke. Endogenous sphingosine 1-phosphate levels are controlled by the expression and activity of sphingosine kinases (SPK). We hypothesize that SPK upregulation mediates preconditioning induced by isoflurane and hypoxia and reduces ischemic injury. Methods-: Male wild-type C57BL/J, SPK1 -/- and SPK2 -/- mice were exposed to isoflurane or hypoxia preconditioning before transient middle cerebral artery occlusion. Infarct volume and neurological outcome were measured 24 hours later. SPK inhibitors (SKI-II and ABC294640) were used to test the involvement of SPK2. Expressions of SPK1, SPK2, and hypoxia-inducible factor 1α were determined. Primary cultures of mouse cortical neurons were exposed to isoflurane before glutamate-or hydrogen peroxide-induced cell death. Results-: Isoflurane preconditioning and hypoxia preconditioning significantly reduced infarct volume and improved neurological outcome in wild-type and SPK1 -/- mice but not in SPK2 -/- mice. Pretreatment with SKI-II or ABC294640 abolished the isoflurane preconditioning-induced tolerance. Western blot showed a rapid and sustained increase in SPK2 level, whereas SPK1 level was similar between preconditioned mice and controls. Hypoxia-inducible factor 1α was upregulated in wild-type isoflurane-preconditioned mice but not in SPK2 -/-. Isoflurane preconditioning protected primary neurons against cell death, which was abolished in ABC294640-treated cells. Conclusions-: Applying genetic and pharmacological approaches, we demonstrate that neuronal SPK2 isoform plays an important role in cerebral preconditioning.

Original languageEnglish (US)
Pages (from-to)199-204
Number of pages6
JournalStroke
Volume43
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Isoflurane
Wounds and Injuries
Brain
Hypoxia-Inducible Factor 1
Cell Death
Lysosphingolipid Receptors
Neurons
sphingosine kinase
Middle Cerebral Artery Infarction
Brain Injuries
Hydrogen Peroxide
Anesthetics
Glutamic Acid
Rodentia
Protein Isoforms
Up-Regulation
Western Blotting
Stroke
Pharmacology
Hypoxia

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Yung, Lai Ming ; Wei, Ying ; Qin, Tao ; Wang, Yumei ; Smith, Charles D. ; Waeber, Christian. / Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. In: Stroke. 2012 ; Vol. 43, No. 1. pp. 199-204.
@article{58955298eb77481abce391903ec36077,
title = "Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury",
abstract = "Background and Purpose-: Cerebral preconditioning provides insights into endogenous mechanisms that protect the brain from ischemic injury. Hypoxia and the anesthetic isoflurane are powerful preconditioning agents. Recent data show that sphingosine 1-phosphate receptor stimulation improves outcome in rodent models of stroke. Endogenous sphingosine 1-phosphate levels are controlled by the expression and activity of sphingosine kinases (SPK). We hypothesize that SPK upregulation mediates preconditioning induced by isoflurane and hypoxia and reduces ischemic injury. Methods-: Male wild-type C57BL/J, SPK1 -/- and SPK2 -/- mice were exposed to isoflurane or hypoxia preconditioning before transient middle cerebral artery occlusion. Infarct volume and neurological outcome were measured 24 hours later. SPK inhibitors (SKI-II and ABC294640) were used to test the involvement of SPK2. Expressions of SPK1, SPK2, and hypoxia-inducible factor 1α were determined. Primary cultures of mouse cortical neurons were exposed to isoflurane before glutamate-or hydrogen peroxide-induced cell death. Results-: Isoflurane preconditioning and hypoxia preconditioning significantly reduced infarct volume and improved neurological outcome in wild-type and SPK1 -/- mice but not in SPK2 -/- mice. Pretreatment with SKI-II or ABC294640 abolished the isoflurane preconditioning-induced tolerance. Western blot showed a rapid and sustained increase in SPK2 level, whereas SPK1 level was similar between preconditioned mice and controls. Hypoxia-inducible factor 1α was upregulated in wild-type isoflurane-preconditioned mice but not in SPK2 -/-. Isoflurane preconditioning protected primary neurons against cell death, which was abolished in ABC294640-treated cells. Conclusions-: Applying genetic and pharmacological approaches, we demonstrate that neuronal SPK2 isoform plays an important role in cerebral preconditioning.",
author = "Yung, {Lai Ming} and Ying Wei and Tao Qin and Yumei Wang and Smith, {Charles D.} and Christian Waeber",
year = "2012",
month = "1",
day = "1",
doi = "10.1161/STROKEAHA.111.626911",
language = "English (US)",
volume = "43",
pages = "199--204",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. / Yung, Lai Ming; Wei, Ying; Qin, Tao; Wang, Yumei; Smith, Charles D.; Waeber, Christian.

In: Stroke, Vol. 43, No. 1, 01.01.2012, p. 199-204.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury

AU - Yung, Lai Ming

AU - Wei, Ying

AU - Qin, Tao

AU - Wang, Yumei

AU - Smith, Charles D.

AU - Waeber, Christian

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background and Purpose-: Cerebral preconditioning provides insights into endogenous mechanisms that protect the brain from ischemic injury. Hypoxia and the anesthetic isoflurane are powerful preconditioning agents. Recent data show that sphingosine 1-phosphate receptor stimulation improves outcome in rodent models of stroke. Endogenous sphingosine 1-phosphate levels are controlled by the expression and activity of sphingosine kinases (SPK). We hypothesize that SPK upregulation mediates preconditioning induced by isoflurane and hypoxia and reduces ischemic injury. Methods-: Male wild-type C57BL/J, SPK1 -/- and SPK2 -/- mice were exposed to isoflurane or hypoxia preconditioning before transient middle cerebral artery occlusion. Infarct volume and neurological outcome were measured 24 hours later. SPK inhibitors (SKI-II and ABC294640) were used to test the involvement of SPK2. Expressions of SPK1, SPK2, and hypoxia-inducible factor 1α were determined. Primary cultures of mouse cortical neurons were exposed to isoflurane before glutamate-or hydrogen peroxide-induced cell death. Results-: Isoflurane preconditioning and hypoxia preconditioning significantly reduced infarct volume and improved neurological outcome in wild-type and SPK1 -/- mice but not in SPK2 -/- mice. Pretreatment with SKI-II or ABC294640 abolished the isoflurane preconditioning-induced tolerance. Western blot showed a rapid and sustained increase in SPK2 level, whereas SPK1 level was similar between preconditioned mice and controls. Hypoxia-inducible factor 1α was upregulated in wild-type isoflurane-preconditioned mice but not in SPK2 -/-. Isoflurane preconditioning protected primary neurons against cell death, which was abolished in ABC294640-treated cells. Conclusions-: Applying genetic and pharmacological approaches, we demonstrate that neuronal SPK2 isoform plays an important role in cerebral preconditioning.

AB - Background and Purpose-: Cerebral preconditioning provides insights into endogenous mechanisms that protect the brain from ischemic injury. Hypoxia and the anesthetic isoflurane are powerful preconditioning agents. Recent data show that sphingosine 1-phosphate receptor stimulation improves outcome in rodent models of stroke. Endogenous sphingosine 1-phosphate levels are controlled by the expression and activity of sphingosine kinases (SPK). We hypothesize that SPK upregulation mediates preconditioning induced by isoflurane and hypoxia and reduces ischemic injury. Methods-: Male wild-type C57BL/J, SPK1 -/- and SPK2 -/- mice were exposed to isoflurane or hypoxia preconditioning before transient middle cerebral artery occlusion. Infarct volume and neurological outcome were measured 24 hours later. SPK inhibitors (SKI-II and ABC294640) were used to test the involvement of SPK2. Expressions of SPK1, SPK2, and hypoxia-inducible factor 1α were determined. Primary cultures of mouse cortical neurons were exposed to isoflurane before glutamate-or hydrogen peroxide-induced cell death. Results-: Isoflurane preconditioning and hypoxia preconditioning significantly reduced infarct volume and improved neurological outcome in wild-type and SPK1 -/- mice but not in SPK2 -/- mice. Pretreatment with SKI-II or ABC294640 abolished the isoflurane preconditioning-induced tolerance. Western blot showed a rapid and sustained increase in SPK2 level, whereas SPK1 level was similar between preconditioned mice and controls. Hypoxia-inducible factor 1α was upregulated in wild-type isoflurane-preconditioned mice but not in SPK2 -/-. Isoflurane preconditioning protected primary neurons against cell death, which was abolished in ABC294640-treated cells. Conclusions-: Applying genetic and pharmacological approaches, we demonstrate that neuronal SPK2 isoform plays an important role in cerebral preconditioning.

UR - http://www.scopus.com/inward/record.url?scp=84855340424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855340424&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.111.626911

DO - 10.1161/STROKEAHA.111.626911

M3 - Article

C2 - 21980199

AN - SCOPUS:84855340424

VL - 43

SP - 199

EP - 204

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 1

ER -